Nilox Mini (Nitroxoline)

Nitroxoline inhibits bacterial enzymes that are essential for DNA synthesis and interferes with nucleic acid replication. By disrupting these processes, it prevents bacterial growth and promotes bacterial death, particularly against organisms commonly found in the urinary tract.

The dosage of Nilox Mini is determined by the prescribing clinician based on the patient’s age, weight, renal function and severity of infection. Healthcare professionals tailor the regimen to achieve optimal therapeutic effect while minimizing risk.

The safety of nitroxoline during pregnancy and lactation has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and alternative agents with known safety profiles are preferred.

To order Nilox Mini, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The most common alternative for urinary tract infections is trimethoprim‑sulfamethoxazole. Nitroxoline offers a different mechanism of action, which can be advantageous in cases of resistance to sulfonamides. Both agents are prescription‑only, but nitroxoline may have a distinct side‑effect profile and drug‑interaction considerations.

Nilox Mini should be stored at ambient temperature, below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments.

Nilox Mini is administered orally, usually with a glass of water. The tablet should be swallowed whole unless the prescriber advises otherwise. It is taken according to the schedule set by the healthcare professional, which may involve dosing with or without food.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, significant liver enzyme elevations indicating hepatic injury, blood dyscrasias like neutropenia, and severe skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience any of these symptoms.

Nilox Mini should be avoided in individuals with known hypersensitivity to nitroxoline or any component of the formulation. Caution is also advised for patients with severe renal or hepatic impairment, and it is generally not recommended for pregnant or breastfeeding women unless clearly indicated by a physician.